The role of soluble factors in MSC-mediated immunoregulation
Authors:
- Е. A. PrymakovaЕPЕ. A. Prymakova
- E. G. YurkinaEYE. G. Yurkina
- N. I. DedyulyaNDN. I. Dedyulya
Open Access
- 18 July 2025
- journal article
- Published by Republican Scientific and Practical Center for Radiation Medicine and Human Ecology in Medical and Biological Problems of Life Activity
- No. 2,p. 21-26
Abstract
It is known that the immunomodulatory functions of mesenchymal stem cells (MSCs) are realized through interdependent immunoregulatory network. Recently, researchers have increasingly been searching for soluble factors and molecules secreted in immunoprivileged organs and tissues and allowing to avoid the immune response. Such molecules can be galectin-1 and HLAG, which expressed on the trophoblast and ensure the development of immunotolerance.The objective of this study was a comparative analysis of the production of soluble HLA-G and galectin-1 molecules, as well as interleukin-10 by intact mesenchymal stem cells and during their co-cultivation with peripheral blood lymphocytes of recipients of allogeneic hematopoietic stem cells.As a result of the study, it was found that for the release of the soluble form of HLA-G and, consequently, the implementation of the immunomodulatory properties of MSCs, interaction between MSCs and peripheral blood lymphocytes is necessary. At the same time, the intercellular interaction of MSCs and lymphocytes did not promote increased production of galectin-1, the main contribution to the production of which in mixed cultures was made by MSCs. The level of soluble HLA-G molecule depended on the concentration of IL-10 in the culture. The revealed patterns indicate that the choice of a biomedical cell product based on MSCs should be carried out taking into account the production of soluble factors characterizing their immunoregulatory potential, which can ultimately increase the effectiveness of cell therapy.Keywords
This publication has 13 references indexed in Scilit:
- Exosomes originating from MSCs stimulated with TGF‐β and IFN‐γ promote Treg differentiationJournal of Cellular Physiology, 2018
- Immunological regulation of trophoblast invasionJournal of Reproductive Immunology, 2011
- New Insights into Mesenchymal Stromal Cell‐Mediated T‐Cell Suppression Through GalectinsScandinavian Journal of Immunology, 2011
- Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10–dependent ILT4/HLA-G pathwayBlood, 2010
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric OxideCell Stem Cell, 2008
- A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cellsCytotherapy, 2008
- Immunosuppressive Effects of Mesenchymal Stem Cells: Involvement of HLA-GTransplantation, 2007
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- Amelioration of graft versus host disease by galectin-1Clinical Immunology, 2003
- Separation of Blood Leucocytes, Granulocytes and LymphocytesTissue Antigens, 1974